Benign Prostatic Hypertrophy.

Men with moderate symptoms of BPH are generally considered the best candidates for drug attention. However, the note between mild and moderate symptoms is arbitrary and there are wide differences in semantic role permissiveness of symptoms. Hence, some men with mild symptoms of BPH require drug tending, whereas a large ratio of men with moderate symptoms prefer watchful waiting or room.
Available drug treatments include alpha-blockers, finasteride and Serenoa repens. These drugs have been previously reviewed in Drugs & Therapy Perspectives.
In the US in 1994, more than 70% of urologists recommended drugs as first-line therapy for BPH in patients with moderate symptoms, whereas 6% of urologists advocated watchful waiting.
However, Predicting Clinical Procession Is DifficultBPH starts to develop when men are in their mid-thirties, and at that time it is not known which men will develop a status that becomes clinically significant.